Name: FDA approves first at-home genetic test to assess breast cancer risk
Uploaded: Fri Mar 09 2018 23:56:15 GMT+0000 (UTC)
Duration: 1 min 16 s
Description: The kit from the company 23andMe tests for three mutations and is available without a prescription — though the test has limitations and it is recommended that the results are confirmed with a doctor.

March 9, 201801:16